Phase Ⅱ and Ⅲ Trial of a SARS-CoV-2 Vaccine LYB001
Clinical trial NCT05137444 · UNKNOWN
Trial details
- NCT number
- NCT05137444
- Sponsor
- Yantai Patronus Biotech Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-01
- Primary completion
- 2023-03-01
- Enrollment
- 1900
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.